Par Drugs and Chemicals Limited — Board Meeting, 11-01-2025: Outcome of Board Meeting

The Board of Directors has reviewed and approved several key decisions, including a slump sale of its existing establishment for ₹95 Crore. The company will also pivot towards clean energy, real estate, and capital market ventures through amendments to its Memorandum of Association. An Extraordinary General Meeting is slated for February 12, 2025, for shareholder approvals, with e-voting commencing on February 9. Additionally, two directors, Mr. Ghanshyam Bhagvanbhai Savani and Mrs. Nayna Jignesh Savani, tendered their resignations, effective January 15, 2025, with Mr. Savani continuing as Production Head.